TNFα can facilitate angiogenesis by increasing epidermal growth factor receptor (EGFR) activity [229]; it induces immune cell suppression through the activation of the NF-κB and STAT3 pathways [230], and decreases the expression of the tumor-suppressor gene PTEN in glioma [231]. The gene discussed is EGFR; the disease is central nervous system cancer.